What bothers severe asthma patients most? A paired patient–clinician study across seven European countries

Autor: Ben Ainsworth, Eleanor Chatburn, Aruna T. Bansal, Olivia Fulton, Dominique Hamerlijnck, Courtney Coleman, Katrien Eger, Michael Hyland, Joshua Holmes, Liam Heaney, Vratislav Sedlák, Sabina Škrgat, Natalija Edelbaher, Anneke ten Brinke, Celeste Porsbjerg, Mina Gaga, Claudia Loureiro, Ratko Djukanovic, Emmanuelle Berret, Namhee Kwon

Publikováno v: ERJ Open Research, Vol 9, Iss 3 (2023)

Introduction Severe asthma is a complex, multidimensional disease. Optimal treatment, adherence and outcomes require shared decision-making, rooted in mutual understanding between patient and clinician. This study used a novel, patient-centred approa

Externí odkaz: https://doaj.org/article/d74f0e8e5d394494b5d21b42499f65d7

The effect of the COVID-19 pandemic on severe asthma care in Europe: will care change for good?

Autor: Katrien Eger, Dora Paroczai, Alison Bacon, Florence Schleich, Svetlana Sergejeva, Arnaud Bourdin, Isabelle Vachier, Eleftherios Zervas, Konstantinos Katsoulis, Dimosthenis Papapetrou, Konstantinos Kostikas, Zsuzsanna Csoma, Enrico Heffler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Jolita Palacionyte, Anneke ten Brinke, Simone Hashimoto, Frank W.J.M. Smeenk, Gert-Jan Braunstahl, Simone van der Sar, Florin Mihălţan, Natalia Nenasheva, Marina Peredelskaya, Biljana Zvezdin, Ivan Čekerevac, Sanja Hromiš, Vojislav Ćupurdija, Zorica Lazic, Branislava Milenkovic, Sanja Dimic-Janjic, Valentyna Yasinska, Barbro Dahlén, Apostolos Bossios, Nikolaos Lazarinis, David Aronsson, Arne Egesten, Abul Kashem Mohammad Munir, Lars Ahlbeck, Christer Janson, Sabina Škrgat, Natalija Edelbaher, Joerg Leuppi, Fabienne Jaun, Jochen Rüdiger, Nikolay Pavlov, Pietro Gianella, Reta Fischer, Florian Charbonnier, Rekha Chaudhuri, Steven James Smith, Simon Doe, Michelle Fawdon, Matthew Masoli, Liam Heaney, Hans Michael Haitchi, Ramesh Kurukulaaratchy, Olivia Fulton, Betty Frankemölle, Toni Gibson, Karen Needham, Peter Howarth, Ratko Djukanovic, Elisabeth Bel, Michael Hyland

Publikováno v: ERJ Open Research, Vol 8, Iss 2 (2022)

Background The coronavirus disease 2019 (COVID-19) pandemic has put pressure on healthcare services, forcing the reorganisation of traditional care pathways. We investigated how physicians taking care of severe asthma patients in Europe reorganised c

Externí odkaz: https://doaj.org/article/1ba0c01adf6240cdb9e3de11142d7ab9

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial

Autor: Job J.M.H. van Bragt, Michiel Alexander de Raaf, Harm Jan Bogaard, Pierre M Bet, Azar Kianzad, Merlijn Reijrink, Esther J. Nossent, Job R Schippers, Lucas R Celant, Lieuwe D. J. Bos, Jeroen N. Wessels, Mirte Muller, Chris Happé, Niels Pronk, Anton Vonk Noordegraaf, Leo M. A. Heunks, Liza Botros, E Marleen Kemper, Wim Boersma, Michel van den Heuvel, Hans P Grotjohan, Rianne J A Hoek, Carolina C Pamplona, Sara Azhang, Nicole P. Juffermans, Marry R Smit, Ivo van der Lee, Imke H Bartelink, Bas F M van Raaij, Janneke E Stalenhoef, Wouter Hoefsloot, Pieter R. Tuinman, Ariana Lammers, Katrien Eger, Boaz D Hazes, E Laurien van der Lee, Karin A T Boomars, Arthur L E M Vanhove, Frances S. de Man, Laura A Hagens, Anke-Hilse Maitland-van der Zee, Elisabeth C W Neefjes, Marcus J. Schultz, Pearl F M Mau Asam, Erik Duijvelaar, Patrick J Smeele, A. Josien Smits, Frank W J M Smeenk, Elise M A Slob, Laurien M A Oswald, Ary Serpa Neto, J. J. Miranda Geelhoed, Jessie Van Wezenbeek, Gert-Jan Braunstahl, Herman M A Hofstee, Romke Hoekstra, Peter I. Bonta, Jurjan Aman, Nienke Paternotte, Renate Kos, Ahmed A. Bayoumy, Peter W A Kunst, Maria J Overbeek, Adinda Mieras, Yurika L E van Glabbeek

Publikováno v: lancet. Respiratory medicine, 9(9), 957-968. Elsevier Limited
The Lancet Respiratory Medicine, 9(9), 957-968. ELSEVIER SCI LTD
The Lancet Respiratory Medicine, 9(9), 957-968. Elsevier Ltd.
Lancet Respiratory Medicine, 9, 957-968
Aman, J, Duijvelaar, E, Botros, L, Kianzad, A, Schippers, J R, Smeele, P J, Azhang, S, Bartelink, I H, Bayoumy, A A, Bet, P M, Boersma, W, Bonta, P I, Boomars, K A T, Bos, L D J, van Bragt, J J M H, Braunstahl, G-J, Celant, L R, Eger, K A B, Geelhoed, J J M, van Glabbeek, Y L E, Grotjohan, H P, Hagens, L A, Happe, C M, Hazes, B D, Heunks, L M A, van den Heuvel, M, Hoefsloot, W, Hoek, R J A, Hoekstra, R, Hofstee, H M A, Juffermans, N P, Kemper, E M, Kos, R, Kunst, P W A, Lammers, A, van der Lee, I, van der Lee, E L, Maitland-van der Zee, A-H, Mau Asam, P F M, Mieras, A, Muller, M, Neefjes, L, Nossent, E J, Oswald, L M A, Overbeek, M J, Pamplona, C, Paternotte, N, Pronk, N, de Raaf, M A, van Raaij, B F M, Reijrink, M, Schultz, M J, Serpa Neto, A, Slob, E M, Smeenk, F W J M, Smit, M R, Smits, A J, Stalenhoef, J E, Tuinman, P R, Vanhove, A L E M, Wessels, J N, van Wezenbeek, J C C, Vonk Noordegraaf, A, de Man, F S & Bogaard, H J 2021, ' Imatinib in patients with severe COVID-19 : a randomised, double-blind, placebo-controlled, clinical trial ', Lancet respiratory medicine, vol. 9, no. 9, pp. 957-968 . https://doi.org/10.1016/S2213-2600(21)00237-X
The Lancet. Respiratory Medicine
Lancet respiratory medicine, 9(9), 957-968. Elsevier Limited
Lancet Respiratory Medicine, 9, 9, pp. 957-968
The Lancet Respiratory Medicine

Background The major complication of COVID-19 is hypoxaemic respiratory failure from capillary leak and alveolar oedema. Experimental and early clinical data suggest that the tyrosine-kinase inhibitor imatinib reverses pulmonary capillary leak. Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::95b9388602de3565960dbc68949c8a0a
https://pure.amc.nl/en/publications/imatinib-in-patients-with-severe-covid19(40a385b0-de53-45cd-aff2-cb6b5cdfc6d3).html

Reply to 'Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma'

Autor: Katrien Eger, Johannes A. Kroes, Anneke ten Brinke, Elisabeth H. Bel

Publikováno v: Journal of Allergy and Clinical Immunology: In Practice, 10(7). American Academy of Allergy, Asthma and Immunology
Journal of Allergy and Clinical Immunology: In Practice, 10(7)
Eger, K, Kroes, J A, ten Brinke, A & Bel, E H 2022, ' Reply to “Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma” ', Journal of Allergy and Clinical Immunology: In Practice, vol. 10, no. 7, pp. 1936 . https://doi.org/10.1016/j.jaip.2022.04.018
Journal of Allergy and Clinical Immunology: In Practice, 10(7). Elsevier

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::298db9050b16a79a306dd9d1aea9451d
https://research.rug.nl/en/publications/60c5b2a2-f11a-4393-b21a-e4389a91fc56

Poor outcome of SARS-CoV-2 infection in patients with severe asthma on biologic therapy

Autor: Elisabeth H. Bel, Anneke ten Brinke, Kornelis W. Patberg, Simone Hashimoto, Simone van der Sar–van der Brugge, Annelies Beukert, Els J.M. Weersink, Katrien Eger, Gert-Jan Braunstahl, Frank W J M Smeenk

Publikováno v: Respiratory Medicine
Respiratory medicine, 177:106287. W.B. Saunders Ltd

Background It is unclear whether asthma and asthma medications increase or decrease the risk of severe COVID-19, and this is particularly true for patients with severe asthma receiving biologics. Objectives The aim of this study was to assess inciden

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf1cda5726120148869c0a94af038f49
http://www.scopus.com/inward/record.url?scp=85098588801&partnerID=8YFLogxK